The facility, equipped with HPLC, UPLC, GC, UV, IR, DSC, KF and others, is expected to offer full-service, integrated clinical packaging, drug supply management and technology solutions to pharmaceutical and biotech clients.
Installation of latest Waters H-Class HPLC/UPLC systems provides maximum flexibility for developing, validating and running assay, dissolution and stability methods, Almac said.
Large capacity Stability chambers provide all the required ICH stability conditions in the new labs.
The new analytical facility complements Almac’s specialty capabilities, including biocatalysis, radiolabeling, and peptide and protein synthesis.
The services are all part of Almac’s comprehensive drug development services, including API and drug product development and GMP manufacture.